EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction

Larissa F L Ferreira iD, Daiana G de A Vasconcelos, Ruth C A Santos, Jivaldo G Ferreira, Alice V Araújo iD, Janaína V Dos Anjos iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Larissa F L Ferreira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Brazil. Hauptthemen laut MEDLINE: Triazoles, Oxadiazoles, Angiotensin II, Angiotensin II Type 1 Receptor Blockers. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco, Universidade Federal de Pernambuco.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a series of novel angiotensin II type 1 receptor (AT 1 R) antagonist candidates containing the 1,2,4‐oxadiazol‐5‐one nucleus and a 1,2,3‐triazole moiety was designed, synthesized, and evaluated. Compounds 7a – j were obtained via a semiconvergent synthetic route employing copper‐catalyzed azide–alkyne cycloaddition (click chemistry), yielding the target molecules in moderate to good yields. Biological activity was assessed through vascular reactivity assays using rat aortic rings in the presence of angiotensin II. Most compounds reduced angiotensin II‐induced contraction, consistent with a putative AT 1 receptor antagonist profile. Among them, compound 7f , bearing a methylenedioxyphenyl substituent, exhibited the most favorable biological profile within the series. The results indicate that electron‐donating groups favor activity, while strongly electron‐withdrawing substituents, such as nitro, are detrimental. Molecular docking studies predicted consistent interactions with key residues, particularly Arg167 and Tyr87, providing a plausible structural rationale for the observed biological activity. In silico ADME predictions indicated acceptable drug‐like properties, including compliance with drug‐likeness filters and a predicted bioavailability score, and no blood–brain barrier permeation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesOxadiazolesAngiotensin IIAngiotensin II Type 1 Receptor BlockersVasoconstrictionAnimalsRatsStructure-Activity RelationshipMolecular Docking SimulationReceptor, Angiotensin, Type 1Molecular StructureAortaDose-Response Relationship, Drug

Stichwörter der Autor:innen

angiotensin receptor blockers (ARBs)click chemistryheterocycleshypertension

Substanzen

TriazolesOxadiazolesAngiotensin IIReceptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor Blockersoxadiazolone

Autor:innen und Institutionen

  • Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Brazil.
  • Vitória Academic Centre (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Pernambuco, Brazil.

ORCID-Profile: Larissa F L Ferreira, Alice V Araújo, Janaína V Dos Anjos

Förderung

  • Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
  • Universidade Federal de Pernambuco

Zitieren

APA

Ferreira, L. F. L., Vasconcelos, D. G. A., Santos, R. C. A., Ferreira, J. G., Araújo, A. V., & Anjos, J. V. D. (2026). Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction. ChemMedChem. https://doi.org/10.1002/cmdc.70460

Vancouver

Ferreira LFL, Vasconcelos DGA, Santos RCA, Ferreira JG, Araújo AV, Anjos JVD. Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction. ChemMedChem. 2026. doi:10.1002/cmdc.70460

BibTeX
@article{Ferreira2026,
  author = {Ferreira, Larissa F L and Vasconcelos, Daiana G de A and Santos, Ruth C A and Ferreira, Jivaldo G and Araújo, Alice V and Anjos, Janaína V Dos},
  title = {Oxadiazolone‐Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II‐Induced Vascular Contraction},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70460}
}
Kostenlos starten →